Literature DB >> 6713636

Sensitive non-radioisotopic method for measuring lipoprotein lipase and hepatic triglyceride lipase in post-heparin plasma.

S Nozaki, M Kubo, Y Matsuzawa, S Tarui.   

Abstract

In this method for measuring lipoprotein lipase (LPL) and hepatic triglyceride lipase (H-TGL) in post-heparin plasma, we determine the released free fatty acids enzymically. After release, they are extracted by Dole 's method (J. Biol. Chem. 235: 2595-2599, 1960), solubilized with Triton X-100, then measured with an enzymic kit (NEFA Kit-K; Nippon Shoji Kaisha Ltd.) after residual turbidity is removed by centrifugation with chloroform. A 5-microL sample of post-heparin plasma suffices to measure the activity of LPL and H-TGL; thus the method is as sensitive as the radioisotopic method. Selective assay of LPL and H-TGL, by adding sodium dodecyl sulfate to inactivate H-TGL or NaCl to inactivate LPL, is also feasible. The mean activities +/- SD of LPL and H-TGL in plasma of normal healthy men were respectively 9.4 +/- 2.3 mumol/h per milliliter (157 +/- 38 U/L) and 20.1 +/- 10.4 (335 +/- 173 U) mumol/h per milliliter (U/L).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6713636

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Increased serum triglyceride clearance and elevated high-density lipoprotein 2 and 3 cholesterol during treatment of primary hypertriglyceridemia with bezafibrate.

Authors:  Nagahiko Sakuma; Reiko Ikeuchi; Takeshi Hibino; Takayuki Yoshida; Seiji Mukai; Sachie Akita; Kazuhiro Yajima; Hiromichi Miyabe; Toshihiko Goto; Norio Takada; Nobuyuki Ohte; Mitoshi Kunimatu; Genjiro Kimura
Journal:  Curr Ther Res Clin Exp       Date:  2003-11

2.  Two cases with transient lipoprotein lipase (LPL) activity impairment: evidence for the possible involvement of an LPL inhibitor.

Authors:  H Nagasaka; H Kikuta; H Chiba; T Murano; H Harashima; A Ohtake; H Senzaki; N Sasaki; I Inoue; S Katayama; K Shirai; K Kobayashi
Journal:  Eur J Pediatr       Date:  2003-01-23       Impact factor: 3.183

3.  Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer.

Authors:  Haoran Yang; Qingmei Deng; Tun Ni; Yu Liu; Li Lu; Haiming Dai; Hongzhi Wang; Wulin Yang
Journal:  Int J Biol Sci       Date:  2021-10-11       Impact factor: 6.580

4.  A novel lipoprotein lipase gene missense mutation in Chinese patients with severe hypertriglyceridemia and pancreatitis.

Authors:  Tan-Zhou Chen; Sai-Li Xie; Rong Jin; Zhi-Ming Huang
Journal:  Lipids Health Dis       Date:  2014-03-19       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.